X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,781 | +367.6% | 373,193 | +732.3% | 0.00% | – |
| Q2 2023 | $86,985 | +32116.7% | 44,838 | +16384.6% | 0.00% | – |
| Q4 2022 | $270 | – | 272 | +27100.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $11,000 | -50.0% | 6,245 | -33.6% | 0.00% | – |
| Q4 2021 | $22,000 | -75.8% | 9,406 | -45.3% | 0.00% | – |
| Q3 2021 | $91,000 | -38.1% | 17,182 | -23.7% | 0.00% | – |
| Q2 2021 | $147,000 | -46.2% | 22,518 | -29.0% | 0.00% | – |
| Q1 2021 | $273,000 | +116.7% | 31,703 | +61.3% | 0.00% | – |
| Q4 2020 | $126,000 | +18.9% | 19,650 | +25.1% | 0.00% | – |
| Q3 2020 | $106,000 | -33.8% | 15,709 | -8.5% | 0.00% | – |
| Q2 2020 | $160,000 | +162.3% | 17,174 | +178.8% | 0.00% | – |
| Q1 2020 | $61,000 | -10.3% | 6,161 | -2.3% | 0.00% | – |
| Q4 2019 | $68,000 | -12.8% | 6,306 | +3.3% | 0.00% | – |
| Q3 2019 | $78,000 | +32.2% | 6,104 | +56.0% | 0.00% | – |
| Q2 2019 | $59,000 | +59.5% | 3,914 | +83.3% | 0.00% | – |
| Q1 2019 | $37,000 | – | 2,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |